InvestorsObserver is giving Athira Pharma Inc (ATHA) an Analyst Rating Rank of 25, meaning ATHA is ranked higher by analysts than 25% of stocks. The average price target for ATHA is $18.5 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating ATHA a Buy today. Find out what this means to you and get the rest of the rankings on ATHA!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Athira Pharma Inc Stock Today?
Athira Pharma Inc (ATHA) stock is up 2.44% while the S&P 500 is lower by -0.31% as of 12:41 PM on Thursday, Jun 30. ATHA has gained $0.07 from the previous closing price of $2.99 on volume of 1,854,649 shares. Over the past year the S&P 500 is down -11.42% while ATHA is lower by -70.12%. ATHA lost -$1.72 per share the over the last 12 months.
Click Here to get the full Stock Report for Athira Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
